Earnings History Data for Cyclerion Therapeutics, Inc. (CYCN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22-03-2023 | AH | CYCN | Cyclerion Therapeutics, Inc. | 31.53 | -0.16 | 0.00 | -0.24 | Cyclerion Therapeutics reports FY results [3/22/2023 4:56 PM] |
0.4505 | -0.07 (-13.37%) |
0.0 | 0.0 (0.00%) |
0.35 - 1.40 | 747,630 | 80,000 | 0 | ||
| 09-08-2022 | AH | CYCN | Cyclerion Therapeutics | 39.00 | -0.31 | -0.34 | 0.00 | Cyclerion Therapeutics reports Q2 results [8/9/2022 5:18 PM] |
0.96 | 0.01 (1.05%) |
1.02 | 0.07 (7.37%) |
0.46 - 3.62 | 237,297 | 260,000 | 111 | ||
| 04-05-2022 | AH | CYCN | Cyclerion Therapeutics | 32.00 | -0.30 | -0.36 | 0.00 | Cyclerion Therapeutics reports Q1 results [5/4/2022 5:40 PM] |
0.71 | -0.04 (-5.33%) |
0.80 | 0.05 (6.27%) |
0.66 - 4.86 | 95,782 | 116,552 | 100 | ||
| 09-11-2021 | AH | CYCN | Cyclerion Therapeutics | 125.00 | -0.26 | -0.29 | 0.00 | Cyclerion Therapeutics EPS beats by $0.09, misses on revenue [11/9/2021 4:54 PM] |
2.63 | -0.14 (-5.05%) |
2.89 | 0.12 (4.33%) |
2.08 - 6.90 | 333,724 | 270,000 | 1,701 | ||